Log in to save to my catalogue

Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human m...

Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human m...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4002225

Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

About this item

Full title

Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

Publisher

New York: Nature Publishing Group US

Journal title

Nature genetics, 2010-01, Vol.42 (1), p.77-82

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Germline mutations in
PARK2
are a well-known cause of the neurodegenerative disorder Parkinson's disease. Here, Timothy Chan and colleagues report somatic mutations and intragenic deletions of
PARK2
in glioblastoma, colon cancer and lung cancer.
Mutation of the gene
PARK2
, which encodes an E3 ubiquitin ligase, is the most comm...

Alternative Titles

Full title

Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4002225

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4002225

Other Identifiers

ISSN

1061-4036

E-ISSN

1546-1718

DOI

10.1038/ng.491

How to access this item